MalarVx is a bio-pharmaceutical company located in the Center for Infectious Disease Research facility in Seattle, Washington. We founded MalarVx to address the myriad challenges of creating a safe, affordable,  effective malaria vaccine using innovative new technologies discovered through research.  It is our passion to bring these solutions out of the lab and to the millions of people who need them.  We are focused on the development of in vitro culture systems for the malaria parasite which will lead to the development of an effective whole-parasite vaccine. We collaborate with researchers in non-profit institutions, university infectious disease programs, foundations committed to solving diseases of the third world, and for-profit pharmaceutical and medical devices companies.